Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
about
An Update on the Effect of Incretin-Based Therapies on β-Cell Function and MassA clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyondLiraglutide and obesity: a review of the data so far.Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist.Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.Peptibodies: An elegant solution for a long-standing problem.
P2860
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@ast
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@en
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@nl
type
label
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@ast
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@en
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@nl
prefLabel
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@ast
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@en
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@nl
P2860
P3181
P356
P1433
P1476
Dulaglutide: an evidence-based ...... e treatment of type 2 diabetes
@en
P2093
Krystal Edwards
Molly Minze
P2860
P3181
P356
10.2147/CE.S55944
P407
P577
2015-01-01T00:00:00Z